22211 WEST INTERSTATE-10, SAN ANTONIO, TX
Other Events
Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues
Reports Significant Growth in CyPath® Lung Sales and New Collaborations
Announces Program to Advance Veteran Lung Health: Philips and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans
Multidisciplinary Physician Panel to Share Real-World Benefits of Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar
Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath® Lung Technology
Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung
FY 2025
Q3
Q2
Q1
Amended Annual Report
FY 2024
Prospectus filed pursuant to Rule 424(b)(4)
Amended Registration Statement for Securities
Effectiveness Notice
S-1
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
PRER14A
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
Post-Effective Amendment to Registration Statement